Moody National Bank Trust Division Sells 2,302 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

Moody National Bank Trust Division lowered its holdings in shares of Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 17.2% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 11,084 shares of the biotechnology company's stock after selling 2,302 shares during the period. Axon Enterprise makes up about 0.7% of Moody National Bank Trust Division's holdings, making the stock its 25th biggest position. Moody National Bank Trust Division's holdings in Axon Enterprise were worth $6,587,000 as of its most recent SEC filing.

Several other institutional investors have also recently added to or reduced their stakes in the business. Public Sector Pension Investment Board raised its holdings in Axon Enterprise by 19.2% during the third quarter. Public Sector Pension Investment Board now owns 3,104 shares of the biotechnology company's stock worth $1,240,000 after buying an additional 500 shares during the last quarter. CIBC Asset Management Inc increased its position in shares of Axon Enterprise by 9.2% during the third quarter. CIBC Asset Management Inc now owns 10,578 shares of the biotechnology company's stock worth $4,227,000 after acquiring an additional 895 shares in the last quarter. Foundations Investment Advisors LLC acquired a new stake in shares of Axon Enterprise in the 3rd quarter worth about $221,000. Sequoia Financial Advisors LLC lifted its position in Axon Enterprise by 4.9% in the 3rd quarter. Sequoia Financial Advisors LLC now owns 1,727 shares of the biotechnology company's stock valued at $690,000 after acquiring an additional 81 shares in the last quarter. Finally, Axxcess Wealth Management LLC acquired a new position in Axon Enterprise during the 3rd quarter valued at about $814,000. 79.08% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

AXON has been the subject of several analyst reports. Morgan Stanley raised Axon Enterprise from an "equal weight" rating to an "overweight" rating and increased their price objective for the stock from $500.00 to $700.00 in a research note on Tuesday, December 3rd. Needham & Company LLC raised their price objective on Axon Enterprise from $525.00 to $600.00 and gave the company a "buy" rating in a research note on Friday, November 8th. TD Cowen started coverage on shares of Axon Enterprise in a report on Wednesday, January 8th. They set a "buy" rating and a $700.00 price objective on the stock. JMP Securities increased their target price on shares of Axon Enterprise from $430.00 to $500.00 and gave the company a "market outperform" rating in a report on Thursday, October 31st. Finally, Northland Securities boosted their price target on shares of Axon Enterprise from $365.00 to $550.00 and gave the stock an "outperform" rating in a report on Monday, November 11th. One analyst has rated the stock with a hold rating and fourteen have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $504.92.

Axon Enterprise Stock Performance

Shares of AXON traded down $1.32 during mid-day trading on Monday, hitting $568.68. The stock had a trading volume of 422,401 shares, compared to its average volume of 713,926. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63. The firm has a market cap of $43.36 billion, a P/E ratio of 146.95, a PEG ratio of 14.19 and a beta of 1.04. Axon Enterprise, Inc. has a 52 week low of $246.99 and a 52 week high of $698.67. The business has a fifty day moving average price of $610.03 and a 200-day moving average price of $452.93.

Insider Buying and Selling at Axon Enterprise

In other news, Director Michael Garnreiter sold 1,000 shares of the stock in a transaction dated Tuesday, October 15th. The shares were sold at an average price of $437.98, for a total value of $437,980.00. Following the sale, the director now directly owns 26,259 shares of the company's stock, valued at approximately $11,500,916.82. This represents a 3.67 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, insider Jeffrey C. Kunins sold 21,834 shares of the business's stock in a transaction that occurred on Tuesday, November 12th. The shares were sold at an average price of $593.88, for a total transaction of $12,966,775.92. Following the transaction, the insider now directly owns 154,394 shares of the company's stock, valued at approximately $91,691,508.72. This represents a 12.39 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 51,545 shares of company stock valued at $31,159,317 over the last three months. 6.10% of the stock is currently owned by insiders.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.